Gill Simba
CIK 0001180763
President & CEODirector
Filings
15
Latest Feb 17, 2026
Issuers covered
3
Showing
15 of 15
Page 1
Track record
4 of 4 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 4 | 75% | +30.8% | +24.0% | +87.4% | -12.1% |
| 90 days | 4 | 75% | -12.0% | +90.6% | +98.5% | -327.6% |
| 180 days | 4 | 100% | +92.6% | +92.6% | +99.6% | +85.6% |
| 365 days | 4 | 100% | +99.5% | +100.0% | +100.0% | +98.1% |
Issuers
Companies where Gill Simba has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| EVLO | Evelo Biosciences, Inc. | 9 | Nov 8, 2023 |
| FHTX | Foghorn Therapeutics Inc. | 4 | Jun 17, 2025 |
| AGE | Agex Therapeutics, Inc. | 2 | Feb 17, 2026 |
All filings
15 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|